These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 24898316)
1. Strategies to reduce bleeding risk in acute coronary syndromes and percutaneous coronary intervention: new and emerging pharmacotherapeutic considerations. Coons JC; Miller T Pharmacotherapy; 2014 Sep; 34(9):973-90. PubMed ID: 24898316 [TBL] [Abstract][Full Text] [Related]
2. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML; Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544 [TBL] [Abstract][Full Text] [Related]
3. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence. Lee MS; Wolfe M; Stone GW JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614 [TBL] [Abstract][Full Text] [Related]
4. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease. Cairns JA; McMurtry MS Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600 [TBL] [Abstract][Full Text] [Related]
5. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes. Ganetsky VS; Hadley DE; Thomas TF Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703 [TBL] [Abstract][Full Text] [Related]
6. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Rubboli A; Halperin JL Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515 [No Abstract] [Full Text] [Related]
7. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody. Roldán V; Marín F Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516 [No Abstract] [Full Text] [Related]
8. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR; Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470 [TBL] [Abstract][Full Text] [Related]
11. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Manoukian SV Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification. Patti G; Di Sciascio G Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304 [TBL] [Abstract][Full Text] [Related]
17. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757 [TBL] [Abstract][Full Text] [Related]
18. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? Hermosillo AJ; Spinler SA Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734 [TBL] [Abstract][Full Text] [Related]
19. Clinical implications and management of bleeding events in patients with acute coronary syndromes. De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962 [TBL] [Abstract][Full Text] [Related]
20. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence]. Páramo JA; García R; Rodríguez P; de Gaona ER Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]